関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
暗号型システインのS-グルタチオニレーションは,タンパク質の折り畳みを阻害することにより,チチンの弾力性を高めます
Jorge Alegre-Cebollada1, Pallav Kosuri2, David Giganti1
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Cell
|March 18, 2014
まとめ
チチンのS-グルタチオニル化.
科学分野:
- バイオフィジックス 生物物理学
- 心血管生物学 心血管生物学
- プロテオミクス プロテオミクスは,プロテオミクスの
背景:
- 巨大な弾性たんぱく質であるチチンは,左心室の詰め込みや心臓病に影響を及ぼします.
- 酸化窒素のシグナリング製品であるS-グルタチオニレーションは,心筋の弾性に影響します.
- ティチンの弾性に対するS-グルタチオニレーションの調節作用は不明である.
研究 の 目的:
- S-グルタチオニレーションがチチンの弾性性を調節する方法を調査する.
- S-グルタチオニレーションが心臓組織力学に影響を与えるメカニズムを探求する.
主な方法:
- タイチン免疫グロブリン (Ig) ドメインの機械的な展開により,システイン残留物を露出します.
- これらの暴露システインのS-グルタチオニル化.
- Igドメインの安定性と折りたたみの変化の評価.
- 人間の心筋細胞の弾性に関する機械化学分析.
主要な成果:
- 機械的な展開は,チチンのIgドメインの暗号的なシステインを暴露する.
- これらのシステインのS-グルタチオニレーションは,Igドメインの安定性と折り畳みを減少させます.
- この変更により,より拡張可能なタイタンを促進します.
- チチンのS-グルタチオニレーションは,ヒトの心筋細胞の弾性性を調節する.
結論:
- チチンの暗号型システインのS-グルタチオニル化により,機械的安定性が低下し,拡張性が増加します.
- この改変は,人間の心筋細胞の弾性性を機械化学的に調節する.
- 暗号的残基の翻訳後の改変は,組織弾性調節のための潜在的な一般的なメカニズムです.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K